2C Tech Corporation, Inc. | Irvine, California
Quantum Dots to treat retinal disease
Studies: Library
Quantum Dots to treat retinal disease
Studies: Library
Qura, Inc. | Boston, Massachusetts
Implantable intraocular pressure sensor
News: Qura receives strategic investment from Santen Ventures
Implantable intraocular pressure sensor
News: Qura receives strategic investment from Santen Ventures
ONL Therapeutics, Inc. | Ann Arbor, Michigan
Pioneering an entirely new approach to preserving sight
News: ONL Therapeutics Closes $4.25 million in Series A Funding
Pioneering an entirely new approach to preserving sight
News: ONL Therapeutics Closes $4.25 million in Series A Funding
LensGen, Inc. | Irvine, California
A biomimetic accommodating intraocular lens
News: LensGen Updates on Juvene IOL, adds $15m to Series A
LensGen® Closes $21 Million Series A Financing
A biomimetic accommodating intraocular lens
News: LensGen Updates on Juvene IOL, adds $15m to Series A
LensGen® Closes $21 Million Series A Financing
Trefoil Therapeutics, LLC | San Diego, California
Developing novel compounds to treat corneal dystrophies
News: Trefoil Therapeutics Raises $5.2 Million Series 1 Financing
Developing novel compounds to treat corneal dystrophies
News: Trefoil Therapeutics Raises $5.2 Million Series 1 Financing
RetroSense Therapeutics, LLC | Irvine, California
(Acquired: Allergan) First in class optogenetics therapy to treat retinal diseases
News: Allergan Acquires Gene Therapy Company RetroSense Therapeutics
(Acquired: Allergan) First in class optogenetics therapy to treat retinal diseases
News: Allergan Acquires Gene Therapy Company RetroSense Therapeutics